Recognizing that every molecule presents its own set of challenges, our clinical drug development teams combine our unique drug and process design capabilities with a premier range of technologies to deliver the right solution for your drug product.
Building on decades of clinical drug design, development and scale-up experience over thousands of compounds, our multidisciplinary project teams routinely develop custom approaches to enhance the bioavailability, efficacy, and performance of drug candidates across oral solid and inhaled product applications.
We will work with you to fully characterize your compound and its problem statements, and tailor the formulation and drug-delivery system to meet rigorous product specifications, even for the most challenging molecules. Our core technologies and expertise address key challenges presented by today's candidate compounds, including:
Benefit from access to our extensive experience with a range of proven enabling technologies, many of which have been developed or advanced by our teams:
Pre-Formulation Team Lead
Tampa, FL, USA
Mark Cappucci serves as the Preformulation Team Lead at Lonza’s site in Tampa, Florida, USA. He has more than 23 years of experience in the pharmaceutical industry, with expertise in areas including drug substance characterization, polymorph identification, and microdosing techniques using Lonza’s Xcelodose® system.